Tracheal Allograft
Tracheal Allograft - Related Videos
02:24
Tracheal Cannulation in Rabbit Model: A Procedure to Insert Tracheal Cannula into the Rabbit Trachea
0 Views •
2025
This video demonstrates the surgical creation of an opening in the rabbit trachea to insert a tracheal cannula for artificially ventilating the lungs.
04:50
Direct Tracheal Instillation of Solutes into Mouse Lung
0 Views •
Cited by 54 •
2010
Intratracheal instillations deliver solutes directly into the lungs. This procedure targets the delivery of the instillate into the distal regions of the lung, and is therefore often incorporated in studies aimed at studying alveoli. We provide a detailed survival protocol for performing intratracheal instillations in mice.
10:20
In vitro Measurements of Tracheal Constriction Using Mice
0 Views •
Cited by 15 •
2012
Transgenic mice have been extremely useful in ascribing physiological function to genes. As such, research in general, and functional studies of airway, in particular, have undergone a remarkable shift toward murine models. Here we provide protocols for in vitro trachea constriction studies to evaluate smooth muscle function in murine airway.
08:35
Examination of Drosophila Larval Tracheal Terminal Cells by Light Microscopy
0 Views •
Cited by 11 •
2013
Here, we present a method for light microscopy analysis of tracheal terminal cells in Drosophila larvae. This method allows for quick examination of branch and lumen morphology in whole animals and would be useful for analysis of individual mutants or screens for mutations affecting terminal cell development.
03:51
Label-Free Neutrophil Separation from Tracheal Secretion Using Spiral Microfluidics Channel
0 Views •
2025
This video demonstrates separating neutrophils from tracheal secretions using a microfluidic device with spiral channels. The device achieves efficient separation based on cell size by utilizing varying thicknesses and trapezoidal-shaped channels. The interplay between forces results in large neutrophils accumulating near the inner wall while erythrocytes and mucin aggregates remain near the outer wall, ensuring effective neutrophil separation.
FAQs
Blood flow supports graft viability after transplantation and helps preserve the structural integrity needed for airway function. Without adequate circulation, the donor segment may not remain healthy enough to heal durably within the recipient. Consequently, successful reconstruction depends not only on placing the graft but also on creating conditions that maintain its living tissue and long-term airway stability.
Because donor tissue can trigger rejection, the recipient’s immune response is a central determinant of graft success. Immunosuppression may be used to control this response, but reducing reliance on such treatment remains an important research goal. The challenge is to protect the graft from rejection while supporting healing and avoiding a prolonged dependence on immune-modifying therapy.
Cryopreservation and decellularization are preparation strategies intended to modify the challenges associated with donor tissue. Cryopreservation preserves the graft for later use, whereas decellularization alters the donor tissue by addressing its cellular components. These approaches seek to improve how the graft is handled or how immune difficulties are managed, while retaining the airway structure required for reconstruction.
This approach may be considered when airway damage is extensive, particularly in complex long-segment defects. The overview identifies trauma, cancer, congenital abnormalities, and severe stenosis as relevant causes. In these settings, the clinical need is not simply to widen a small narrowed area, but to address a substantial loss or injury of tracheal airway continuity.
The reconstruction must coordinate preservation of the airway’s physical structure, establishment of blood flow to the graft, and control of the recipient’s immune response. These requirements are interdependent: structural preservation supports airway form, circulation supports graft viability, and immune control limits rejection. Managing all three helps determine whether healing can progress toward a durable airway.
Research is focused on improving graft viability, reducing the need for immunosuppression, and promoting durable airway healing. These priorities address the main barriers to sustained success rather than only the initial reconstruction. Progress could make tracheal allografts more reliable for complex defects and broaden their usefulness in medicine while limiting complications associated with long-term immune control.